Avid Bioservices Inc (CDMO)

[djohn]

Basically everything in the 8K corporate presentation are things we already know. We know if the company increases revenue the margins will get better. We know is we fill capacity we will have a profitable company(at full capacity very profitable) WE NEED NEW BUSINESS!
Dec. 6, 2022 our FY 2023 revenue guidance was $145-$150 million
One year later as of today before the CC our FY 2024 revenue guidance is $145-$165 million
I look on Linkedin and most of our 6 or 7 members of our commercial team have been on board more than a year.
If Matthew Kwietniak Chief Commercial Officer is not on the CC this afternoon explaining how Avid's sales team will move forward and fill the capacity, I will be very disappointed.
I was in sales for over 40 years in good markets and bad markets but I was always expected to produce! NO EXCUSES!
They have had the Mammaliam CGMP expansion available for sale for over a year
We need a large increase in guidance to around $200 million and Q rev move towards $50 million fast or we are in deep do do. Short term.
We playing with fire here. If we don't increase rev fast we risk someone swooping in and buying us for a price nobody will like.